2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$10.09+$0.14 (+1.42%)
Price as of Nov 20, 2026 7:54 PM EST- $8.5BMarket Cap
- -38.54%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$10.09+$0.14 (+1.42%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.95 | ||
Change | -$0.62 (-5.87%) | ||
Open | $10.28 | ||
High | $10.61 | ||
Low | $9.89 | ||
Previous Close | $10.57 | ||
Volume | 7,220,139 | ||
30-Day Average Volume | 6,555,946 | ||
1-Week Change | -29.68% | ||
1-Month Change | -38.16% | ||
1-Year Change | -38.54% | ||
3-Year Change | 400.00% | ||
5-Year Change | 85.98% | ||
Fundamentals | |||
Shares Outstanding | 799.8M | ||
Total Assets | $692.9M | ||
Market Cap | $8.5B | ||
Enterprise Value | $8.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$208.4M | ||
Free Cash Flow | -$160.2M | ||
EBIT | -$208.4M | ||
EBITDA | -$208.3M | ||
Net Working Capital | $550.5M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -38 | ||
PEG | -5 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue